Skip to content

A randomised controlled study of acupotomy for chronic neck pain and the mechanism of functional brain connectivity network

A randomised controlled study of acupotomy for chronic neck pain and the mechanism of functional brain connectivity network

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002284
Enrollment
Unknown
Registered
2025-11-21
Start date
2025-11-25
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Neck Pain

Interventions

Acupotomy group:Acupotomy
Drug control group:Oral celecoxib

Sponsors

Zhongshan Torch Development Zone People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Those who meet the Western diagnostic criteria for cervical spondylosis/radiculopathy and have not undergone surgical treatment; 2) Chief complaint is neck and shoulder pain; 3) Disease duration = 3 months; 4) Age between 18 and 75 years old; 5) 3 points = VAS score = 8 points; 6) Those who are conscious able to express their opinions clearly and sign informed consent forms.

Exclusion criteria

Exclusion criteria: 1) Suffering from serious cardiovascular cerebrovascular liver kidney and other systemic diseases the researcher believes that they are not suitable to participate in the study; 2) Individuals diagnosed with severe mental disorders such as schizophrenia and major depression in the past or present; 3) Individuals who have taken antidepressants analgesics steroids and other medications within the past 30 days; 4) Those who have received other clinical trials or acupuncture and moxibustion treatment in the past 30 days; 5) Pregnant or lactating female patients; 6) Refuse patients with needle knife or any contraindications for needle knife; 7) Individuals who are not suitable for magnetic resonance imaging (MRI) due to factors such as metal implantation or fear of sealing in the body; 8) Individuals who are allergic to experimental drugs or have relevant contraindications; 9) Patients with high risk of bleeding due to the combination of blood diseases and the use of anticoagulant drugs.

Design outcomes

Primary

MeasureTime frame
Neck Disability Index;Visual Analog Scale;

Secondary

MeasureTime frame
The Short-From-36 Health Survey;Self-Rating Anxiety Scale;functional magnetic resonance Imaging fMRI;range of motion ( ROM) of cervical spine;

Countries

China

Contacts

Public ContactYingying Liao

Zhongshan Torch Development Zone People's Hospital

edith87@163.com18813849751

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026